Maximize Profitability, Fiscal Transparency and Strategic Agility with High-Impact Gross to Net Accounting Methods
Forward-looking pharmaceutical and life science companies know that gross-to-net accounting is more than just a administrative obligation. In order to stay ahead of the competition and successfully navigate the complex world of payer contracts, pricing and future market demand, industry leaders must have access to accurate and meaningful GTN insights to base their decisions off. However, despite the critical nature of GTN accounting from both a regulatory and commercial standpoint, many in the industry still rely on cumbersome, excel-based manual accounting processes and all but fail to provide business leaders with the strategic insight necessary to improve decision making. Whether you have yet to embark on your GTN optimization journey or are already reaping the benefits of a fully automated and integrated GTN system, we at IQPC invite you to join your fellow GTN peers at the Pharmaceutical Gross to Net Accounting Summit taking place June 27-28 in New Jersey to:
- Discuss the latest trends and thought leadership regarding risk-based pricing, value-based contracting and other next generation pricing/contracting initiatives
- Explore new ways to engage and collaborate with key external stakeholders such as patient advocacy groups, insurance companies, specialty contractors, etc. to enhance the contract negotiation process for all parties involved
- Discover new tools and solutions for effectively collecting, analyzing and communicating RWE, Outcomes and Population-Based Data to help pave the way to value-based pricing
- And more!
If you’re looking to revolutionize GTN accounting at your organization, you won’t want to miss out on this groundbreaking event that will equip you with the insight and resources necessary to break free of manual accounting process! We look forward to seeing you in June.